Cargando…
The evolution of non-small cell lung cancer metastases in TRACERx
Metastatic disease is responsible for the majority of cancer-related deaths(1). We report the longitudinal evolutionary analysis of 126 non-small cell lung cancer (NSCLC) tumours from 421 prospectively recruited patients in TRACERx who developed metastatic disease, compared with a control cohort of...
Ejemplares similares
-
Evolutionary characterisation of lung adenocarcinoma morphology in TRACERx
por: Karasaki, Takahiro, et al.
Publicado: (2023) -
The evolution of lung cancer and impact of subclonal selection in TRACERx
por: Frankell, Alexander M., et al.
Publicado: (2023) -
Body composition and lung cancer-associated cachexia in TRACERx
por: Al-Sawaf, Othman, et al.
Publicado: (2023) -
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
por: Abbosh, Christopher, et al.
Publicado: (2023) -
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
por: Jamal-Hanjani, Mariam, et al.
Publicado: (2014)